Next, we examined the relationship between differential CBX expression with clinical stages of HCC patients, and found significant variations in CBX1, CBX2, CBX3, and CBX5 groups, but no significant changes in CBX4, CBX6, CBX7, and CBX8 groups (Figure 1B). This evidence concerns the gene CBX6 and hepatocellular carcinoma.